These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6428688)

  • 21. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease.
    de Ritis G; Auricchio S; Jones HW; Lew EJ; Bernardin JE; Kasarda DD
    Gastroenterology; 1988 Jan; 94(1):41-9. PubMed ID: 3335296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An in vitro model for gluten enteropathy.
    Nutr Rev; 1980 Apr; 38(4):161-3. PubMed ID: 7207883
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro activation of adenylate cyclase of atrophic celiac intestinal mucosa by wheat gliadin-derived peptides.
    Beguinot L; Auricchio S; Bernardin JE; de Ritis G; De Vincenzi M; Kasarda DD; Macchia V; Silano V
    Pediatr Res; 1986 Jan; 20(1):42-4. PubMed ID: 3945514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity of wheat flour proteins and protein-derived peptides for in vitro developing intestine from rat fetus.
    De Ritis G; Occorsio P; Auricchio S; Gramenzi F; Morisi G; Silano V
    Pediatr Res; 1979 Nov; 13(11):1255-61. PubMed ID: 390482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro intestinal cytotoxicity of various fractions from gliadin or cows's milk proteins in children: quantitative assessment by a morphometric method].
    Olives JP; Schmitz J; Jos J; de Tand MF; Rey J
    Gastroenterol Clin Biol; 1982; 6(6-7):557-62. PubMed ID: 7117767
    [No Abstract]   [Full Text] [Related]  

  • 26. Stimulation of lymphocytes from patients with coeliac disease by subfraction of gluten.
    Lancet; 1976 Sep; 2(7986):629-30. PubMed ID: 61364
    [No Abstract]   [Full Text] [Related]  

  • 27. A catalogue of Triticum monococcum genes encoding toxic and immunogenic peptides for celiac disease patients.
    Vaccino P; Becker HA; Brandolini A; Salamini F; Kilian B
    Mol Genet Genomics; 2009 Mar; 281(3):289-300. PubMed ID: 19104838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic effects of wheat gliadin-derived peptides.
    Paganuzzi AS; Zucco F; Cardelli M; de Angelis I; Mattei R; Pino A; Rocca E; Zampaglioni F
    Toxicology; 1985 Dec; 37(3-4):225-32. PubMed ID: 4071551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides.
    Auricchio S; De Ritis G; De Vincenzi M; Magazzù G; Maiuri L; Mancini E; Minetti M; Sapora O; Silano V
    Gastroenterology; 1990 Oct; 99(4):973-8. PubMed ID: 2394351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wheat starch, gliadin, and the gluten-free diet.
    Thompson T
    J Am Diet Assoc; 2001 Dec; 101(12):1456-9. PubMed ID: 11762742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gliadin, glutenin or both? The search for the Holy Grail in coeliac disease.
    Howdle PD
    Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):703-6. PubMed ID: 16772825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal behavior after intracerebral injection of polypeptides from wheat gliadin: possible relevance to schizophrenia.
    Dohan FC; Levitt DR; Kushnir LD
    Pavlov J Biol Sci; 1978; 13(2):73-82. PubMed ID: 567316
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention by a decapeptide from durum wheat of in vitro gliadin peptide-induced apoptosis in small-bowel mucosa from coeliac patients.
    Silano M; Leonardi F; Trecca A; Mancini E; Di Benedetto R; De Vincenzi M
    Scand J Gastroenterol; 2007 Jun; 42(6):786-7. PubMed ID: 17506006
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter: Sequence comparison of gamma-gliadin and coeliac-toxic alpha-gliadin.
    Patey AL; Evans DJ; Tiplady R; Byfield PG; Matthews EW
    Lancet; 1975 Oct; 2(7937):718. PubMed ID: 52101
    [No Abstract]   [Full Text] [Related]  

  • 35. Gliadin does not induce mucosal inflammation or basophil activation in patients with nonceliac gluten sensitivity.
    Bucci C; Zingone F; Russo I; Morra I; Tortora R; Pogna N; Scalia G; Iovino P; Ciacci C
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1294-1299.e1. PubMed ID: 23639603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agglutinating activity of wheat gliadin peptide fractions in coeliac disease.
    De Vincenzi M; Dessi MR; Giovannini C; Maialetti F; Mancini E
    Toxicology; 1995 Jan; 96(1):29-35. PubMed ID: 7863509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The binding of a glycopeptide component of wheat gluten to intestinal mucosa of normal and coeliac human subjects.
    Douglas AP
    Clin Chim Acta; 1976 Dec; 73(2):357-61. PubMed ID: 1000854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Coeliac disease--new clinical findings and diagnostic tools].
    Lundin KE; Farstad IN; Sollid LM
    Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3226-9. PubMed ID: 14714016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The toxicity of certain cereal proteins in coeliac disease.
    Cornell HJ; Townley RR
    Gut; 1974 Nov; 15(11):862-9. PubMed ID: 4455563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture.
    Shidrawi RG; Day P; Przemioslo R; Ellis HJ; Nelufer JM; Ciclitira PJ
    Scand J Gastroenterol; 1995 Aug; 30(8):758-63. PubMed ID: 7481543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.